Table 3. Clinical risk factors and scores related to postoperative pancreatic fistula after RPD.
| Risk factor, parameter | Patients (n=55) | Points |
|---|---|---|
| Pancreatic texture | ||
| Firm/hard | 20 | 0 |
| Soft | 35 | 2 |
| MPD diameter (mm) | ||
| ≥5 | 5 | 0 |
| 4 | 12 | 1 |
| 3 | 16 | 2 |
| 2 | 18 | 3 |
| ≤1 | 4 | 4 |
| EBL (mL) | ||
| ≤400 | 47 | 0 |
| 400–700 | 4 | 1 |
| 700–1,000 | 1 | 2 |
| >1,000 | 3 | 3 |
| Pathology | ||
| PDAC or chronic pancreatitis | 13 | 0 |
| All others | 42 | 1 |
| CRS-POPF | ||
| Negligible risk | 3 | 0 |
| Low risk | 6 | 1‒2 |
| Intermediate risk | 43 | 3‒6 |
| High risk | 3 | 7‒10 |
RPD, robotic pancreaticoduodenectomy; MPD, main pancreatic duct; EBL, estimated blood loss; PDAC, pancreatic adenocarcinoma; CRS-POPF, clinical risk scores for postoperative pancreatic fistula.